Treatment of ovarian cancer using an anticancer agent conjugated to an Angiopep-2 analog

Details for Australian Patent Application No. 2010239069 (hide)

Owner Angiochem Inc

Inventors Castaigne, Jean-Paul; Demeule, Michel; Lawrence, Betty

Agent Pizzeys

Pub. Number AU-A-2010239069

PCT Pub. Number WO2010/121379

Priority 61/171,040 20.04.09 US

Filing date 20 April 2010

Wipo publication date 28 October 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/121379 Priority application(s): WO2010/121379

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239073-Metal cord reinforced flexible pipe

2010239067-Method and apparatus for accommodating duplicate MAC addresses